Closed · W81XWH-10-ARP-CTA · CFDA 12.420 · Discretionary
DoD Autism Clinical Trial Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 28, 2010
- Close date
- 2
- Expected awards
The verdict
DoD Autism Clinical Trial Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Autism Clinical Trial Award is closed (last close July 28, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed July 28, 2010
Est. Total Funding
$3,200,000
Expected Awards
2
Instrument
Grant
Description
The ARP Clinical Trial Award mechanism was first offered in FY09. Since then, nine Clinical Trial Award applications have been received, and one has been recommended for funding.The ARP Clinical Trial Award supports clinical trials with the potential to have a major impact on the lives of individuals with ASD. Funding from this award mechanism must support a clinical trial. In general, a clinical trial is defined as a prospective accrual of volunteers for a study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects. The proposed clinical trial is expected to begin no later than 12 months after the award date.Clinical Trial Award applications should:• Demonstrate availability of, and access to, a suitable population that will support a meaningful outcome for the study. Discuss how accrual goals will be achieved and how standards of care may impact the study population.• Describe clearly defined, focused endpoints for the proposed clinical trial that correspond to the design and sample size proposed.• Include pharmacokinetic and pharmacodynamic outcomes, if applicable. Clearly articulate the statistical analyses plan. Include a power analysis reflecting sample size projections that will clearly answer the objectives of the study.• Include a study coordinator who will guide the clinical protocol through Institutional Review Board (IRB), Human Subjects Research Review Board (HSRRB), and other regulatory approval processes; coordinate activities from all sites participating in the trial, and coordinate participant accrual.• Demonstrate institutional support.• Discuss the potential impact of the study results for individuals with ASD.If the study is in support of an application to the U.S. Food and Drug Administration, an Investigational New Drug (IND) or an Investigational Device Exemption (IDE) application should be submitted prior to the grant application submission. The Government reserves the right to withdraw funding if an active exemption from marketing approval for the IND or IDE has not been acquired within 6 months of the award date.Preliminary data (may be from outside of the ASD research field), unpublished results from the laboratory of the Principal Investigator (PI), research team, or collaborators named on this application, that is relevant to the proposed research project, is required. Proposals should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.Use of Human Subjects and Human Biological Substances: All Department of Defense (DOD)-funded research involving human subjects and human biological substances must be reviewed and approved by the United States Army Medical Research and Materiel Command (USAMRMC) Office of Research Protections (ORP), Human Research Protection Office (HRPO), in addition to local IRBs. NOTE: Local IRB approval at the time of submission is NOT required. The HRPO is mandated to comply with specific laws and directives governing all research involving human subjects that is conducted or supported by the DOD. These laws and directives are rigorous and detailed, and will require information in addition to that supplied to the local review board. Allow a minimum of 6 months for regulatory review and approval processes for studies involving human subjects. Refer to the General Application Instructions, Appendix 5, for regulatory requirements.
Catch-all / unrestricted eligibility mark · W81XWH-10-ARP-CTA
Grants.gov marks DoD Autism Clinical Trial Award with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Autism Clinical Trial Award is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |